Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Simpson

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Histopathology|February 22, 2018
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancersAshwini Raghavendra, Priyakshi Kalita-de Croft, Ana C Vargas, et al.
Endocrine Pathology|April 19, 2011
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridizationLeonard Da Silva, Daniel James, Peter T Simpson, et al.
Virchows Archiv : an International Journal of Pathology|May 28, 2020
Digital spatial profiling application in breast cancer: a user's perspectiveAmy E McCart Reed, James Bennett, Jamie R Kutasovic, et al.
The American Journal of Surgical Pathology|April 2, 2008
Aberrant expression of E-cadherin in lobular carcinomas of the breastLeonard Da Silva, Suzanne Parry, Lynne Reid, et al.
ACS Infectious Diseases|February 11, 2017
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis ProteasomeKyle A Totaro, Dominik Barthelme, Peter T Simpson, et al.
The Journal of Pathology. Clinical Research|June 18, 2025
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasisVaibhavi Joshi, Andrew Stacey, Yufan Feng, et al.
Molecular Pharmaceutics|November 16, 2023
Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain MetastasisMalcolm Lim, Nicholas L Fletcher, Jodi M Saunus, et al.
Virchows Archiv : an International Journal of Pathology|August 15, 2013
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancerAmy E McCart Reed, Sarah Song, Jamie R Kutasovic, et al.
The Journal of Pathology|March 3, 2004
Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissuePeter T Simpson, Theodora Gale, Jorge S Reis-Filho, et al.
Histopathology|May 13, 2025
ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selectionAnna Sokolova, Vaibhavi Joshi, Haarika Chittoory, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Histopathology|February 22, 2018
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancersAshwini Raghavendra, Priyakshi Kalita-de Croft, Ana C Vargas, et al.
Endocrine Pathology|April 19, 2011
Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridizationLeonard Da Silva, Daniel James, Peter T Simpson, et al.
Virchows Archiv : an International Journal of Pathology|May 28, 2020
Digital spatial profiling application in breast cancer: a user's perspectiveAmy E McCart Reed, James Bennett, Jamie R Kutasovic, et al.
The American Journal of Surgical Pathology|April 2, 2008
Aberrant expression of E-cadherin in lobular carcinomas of the breastLeonard Da Silva, Suzanne Parry, Lynne Reid, et al.
ACS Infectious Diseases|February 11, 2017
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis ProteasomeKyle A Totaro, Dominik Barthelme, Peter T Simpson, et al.
The Journal of Pathology. Clinical Research|June 18, 2025
NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasisVaibhavi Joshi, Andrew Stacey, Yufan Feng, et al.
Molecular Pharmaceutics|November 16, 2023
Targeted Hyperbranched Nanoparticles for Delivery of Doxorubicin in Breast Cancer Brain MetastasisMalcolm Lim, Nicholas L Fletcher, Jodi M Saunus, et al.
Virchows Archiv : an International Journal of Pathology|August 15, 2013
Thrombospondin-4 expression is activated during the stromal response to invasive breast cancerAmy E McCart Reed, Sarah Song, Jamie R Kutasovic, et al.
The Journal of Pathology|March 3, 2004
Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissuePeter T Simpson, Theodora Gale, Jorge S Reis-Filho, et al.
Histopathology|May 13, 2025
ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selectionAnna Sokolova, Vaibhavi Joshi, Haarika Chittoory, et al.
Pageof 11